Advertisement
CI vs ELV
Which Stock Would AI Choose? The Cigna Group (CI) vs. Elevance Health (ELV) Stock Comparison
Key Takeaways
- The Cigna Group (CI) trades at a lower trailing P/E ratio (price-to-earnings ratio) of 12.74 compared to Elevance Health's (ELV) 15.08, suggesting a more attractive valuation.
- ELV recently reported strong Q1 2026 results, beating EPS (earnings per share) estimates and raising full-year guidance, driving short-term momentum.
- CI faces a CEO transition but maintains a higher dividend yield of 2.21% versus ELV's 1.93%, appealing to income-focused investors.
- Both stocks show modest YTD (year-to-date) gains around 2-3%, amid sector pressures from regulatory scrutiny and medical costs.
- CI's market cap stands at $74.5B, slightly below ELV's $77.3B, with CI exhibiting lower beta (0.27 vs. 0.50) for reduced volatility.
Introduction
This stock comparison examines CI and ELV, two leading players in the managed healthcare sector. Both companies provide health insurance and related services, navigating similar challenges like rising medical costs and regulatory changes. Traders seeking short-term momentum and investors focused on valuation or dividends may find value in analyzing their relative performance, recent catalysts, and market positioning. In the current environment of steady sector growth but heightened scrutiny, understanding these contrasts aids informed decision-making in healthcare stock portfolios.
CI Overview and Recent Performance
The Cigna Group (CI) is a global health services organization offering medical, dental, disability, and pharmacy benefit management through subsidiaries like Express Scripts. In recent market activity, shares have traded around $282, within a 52-week range of $239.51 to $350.00. Performance has been stable, with modest gains in recent weeks amid anticipation for Q1 earnings and a confirmed quarterly dividend of $1.56 per share. Sentiment has been influenced by CEO David Cordani's planned transition and concerns over declining premiums in certain segments, though strong revenue of $274.9B TTM (trailing twelve months) and EPS of $22.18 underscore operational resilience. Lower forward P/E of 9.31 reflects expectations of earnings growth despite regulatory pressures.
ELV Overview and Recent Performance
Elevance Health (ELV), formerly Anthem, delivers health benefits through employer, individual, Medicaid, and Medicare plans, with growing emphasis on care management. Shares recently hovered near $356, in a 52-week range from $273.71 to $424.24. Recent weeks saw upward momentum following Q1 2026 results, with revenue of $50.2B, adjusted EPS beating estimates at $12.58, and raised full-year EPS guidance to at least $26.75. This reflects effective cost controls and membership stability, boosting sentiment despite broader sector headwinds like medical loss ratios. TTM revenue reached $200.42B with EPS of $23.61, supporting a market cap of $77.3B.
Trending AI Robots
Tickeron's Trending AI Robots page showcases over 25 top-performing AI trading bots curated from a library of 351, tailored to current market conditions across stocks, ETFs, and crypto. These bots employ diverse strategies—from technical pattern recognition to fundamental analysis—spanning timeframes like 5-minute expert trades to 60-minute intermediate signals, with risk levels from low to high volatility. Virtual and brokerage agents offer risk management and real-time signals without minimum balances, enabling copy trading in promising sectors. This selection highlights bots with strong historical edges, such as high win rates in growth areas. Explore these tools to enhance your trading with data-driven automation.
Head-to-Head Comparison
Both CI and ELV operate in managed healthcare but differ in focus: CI emphasizes pharmacy benefits management (PBM) via Express Scripts, diversifying revenue, while ELV prioritizes integrated health plans with Medicaid and Medicare exposure. Growth drivers include CI's international expansion versus ELV's domestic care services scale. Recent momentum favors ELV post-earnings, contrasting CI's steadier but flatter trajectory amid leadership shifts. Risk factors overlap in regulatory risks (e.g., prior authorizations) and medical cost trends, but CI's higher debt/equity (75%) adds leverage sensitivity versus ELV's efficiency gains via AI. Market sentiment leans positive for ELV's catalysts, while CI offers value via lower multiples and higher yield in a stable sector outlook.
Tickeron AI Verdict
Tickeron's AI models would currently lean toward ELV for its trend consistency, recent earnings beat, raised guidance, and margin expansion signals, positioning it favorably amid healthcare volatility. CI remains compelling for value-oriented strategies given its discounted P/E and dividend, but lacks ELV's near-term catalysts. Relative strength suggests higher probability of outperformance for ELV in coming weeks, though both warrant monitoring for Q1 results and sector dynamics.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CI is a Hold and ELV is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CI’s FA Score shows that 1 FA rating(s) are green whileELV’s FA Score has 1 green FA rating(s).
- CI’s FA Score: 1 green, 4 red.
- ELV’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CI’s TA Score shows that 3 TA indicator(s) are bullish while ELV’s TA Score has 4 bullish TA indicator(s).
- CI’s TA Score: 3 bullish, 5 bearish.
- ELV’s TA Score: 4 bullish, 5 bearish.
Price Growth
CI (@Managed Health Care) experienced а -4.00% price change this week, while ELV (@Managed Health Care) price change was -1.76% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +0.72%. For the same industry, the average monthly price growth was +14.43%, and the average quarterly price growth was +37.57%.
Reported Earning Dates
CI is expected to report earnings on Jul 30, 2026.
ELV is expected to report earnings on Jul 22, 2026.
Industries' Descriptions
@Managed Health Care (+0.72% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| CI | ELV | CI / ELV | |
| Capitalization | 74.9B | 85.8B | 87% |
| EBITDA | 12.1B | N/A | - |
| Gain YTD | 3.651 | 13.784 | 26% |
| P/E Ratio | 11.96 | 16.73 | 71% |
| Revenue | 268B | 200B | 134% |
| Total Cash | 7.8B | N/A | - |
| Total Debt | 30.9B | 31.8B | 97% |
CI | ELV | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 62 | 71 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 74 | 91 | |
SMR RATING 1..100 | 56 | 98 | |
PRICE GROWTH RATING 1..100 | 57 | 47 | |
P/E GROWTH RATING 1..100 | 81 | 37 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CI's Valuation (5) in the Managed Health Care industry is in the same range as ELV (7). This means that CI’s stock grew similarly to ELV’s over the last 12 months.
CI's Profit vs Risk Rating (74) in the Managed Health Care industry is in the same range as ELV (91). This means that CI’s stock grew similarly to ELV’s over the last 12 months.
CI's SMR Rating (56) in the Managed Health Care industry is somewhat better than the same rating for ELV (98). This means that CI’s stock grew somewhat faster than ELV’s over the last 12 months.
ELV's Price Growth Rating (47) in the Managed Health Care industry is in the same range as CI (57). This means that ELV’s stock grew similarly to CI’s over the last 12 months.
ELV's P/E Growth Rating (37) in the Managed Health Care industry is somewhat better than the same rating for CI (81). This means that ELV’s stock grew somewhat faster than CI’s over the last 12 months.
| CI | ELV | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 66% |
| Stochastic ODDS (%) | 2 days ago 72% | 2 days ago 62% |
| Momentum ODDS (%) | 2 days ago 54% | 2 days ago 65% |
| MACD ODDS (%) | 2 days ago 57% | 2 days ago 63% |
| TrendWeek ODDS (%) | 2 days ago 53% | 2 days ago 58% |
| TrendMonth ODDS (%) | 2 days ago 50% | 2 days ago 56% |
| Advances ODDS (%) | 14 days ago 63% | 16 days ago 56% |
| Declines ODDS (%) | 6 days ago 55% | 6 days ago 56% |
| BollingerBands ODDS (%) | N/A | 2 days ago 67% |
| Aroon ODDS (%) | 2 days ago 43% | 2 days ago 45% |
Advertisement
CI and
Correlation & Price change
A.I.dvisor indicates that over the last year, CI has been loosely correlated with CVS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CI jumps, then CVS could also see price increases.
ELV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ELV has been loosely correlated with UNH. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ELV jumps, then UNH could also see price increases.